Quick infos Trade prices Volume: Market Cap: 157.39M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: No Dividends Next ER: November 2, 2022 After Market Closes
Company Profile INmune Bio, Inc. is focused on modulating components of the innate immune system to activate an immune response against cancer and Alzheimer?s disease.
Earnings History Date EPS / Forecast Revenue / Forecast March 2, 2023 November 11, 2022 - / -0.547- / -August 3, 2022 -0.38 / -0.486316K / -Beat! May 5, 2022 -0.39 / -0.5661163K / -Beat! March 3, 2022 -0.57 / -0.5755183.5K / 167KBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 3, 2022 10.10 9.90 10.38
9.90
62.54K 4.12% Aug 2, 2022 9.70 9.01 9.72
8.95
96.38K 7.30% Aug 1, 2022 9.04 9.01 9.29
8.92
38.31K 0.78% Jul 29, 2022 8.97 9.00 9.17
8.85
45.85K -1.75% Jul 28, 2022 9.13 9.20 9.26
8.90
34.80K -0.98% Jul 27, 2022 9.22 8.80 9.30
8.53
32.55K 4.77% Jul 26, 2022 8.80 8.78 9.20
8.57
50.59K -1.46% Jul 25, 2022 8.93 9.24 9.39
8.73
104.39K -4.29% Jul 22, 2022 9.33 10.06 10.06
9.10
60.91K -6.61% Jul 21, 2022 9.99 10.16 10.30
9.73
38.56K -1.09% view more
NYSE - New York Stock Exchange
More profiles and info about the company News
INmune Bio, Inc. to Host Earnings Call finance.yahoo.com May 25, 2022 2:45 pm
INmune Bio, Inc. to Host Earnings Call finance.yahoo.com May 25, 2022 2:30 pm
INmune (INMB) Announces Positive Data for its AD Candidate finance.yahoo.com May 25, 2022 11:33 am
INMUNE BIO, INC. ANNOUNCES $40 MILLION REGISTERED DIRECT OFFERING finance.yahoo.com May 25, 2022 9:02 am
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping finance.yahoo.com May 25, 2022 8:05 am
INmune Bio, Inc. Announces First Patient Treated with NK cell priming pseudokine INKmune in High-Risk Myelodysplastic Syndrome (MDS) finance.yahoo.com May 25, 2022 8:00 am
INmune Bio stock plunges after clinical hold of IND of Alzheimer's treatment prompts analyst downgrade marketwatch.com May 24, 2022 8:59 am
INmune Bio, Inc. to Present at the H.C. Wainwright Global Hybrid Investment Conference on May 24th finance.yahoo.com May 18, 2022 9:00 am
INmune Bio, Inc. (INMB) Q1 2022 Earnings Call Transcript fool.com May 6, 2022 1:30 pm
What Type Of Shareholders Make Up INmune Bio, Inc.'s (NASDAQ:INMB) Share Registry? finance.yahoo.com May 3, 2022 11:44 am
INmune Bio, Inc. to Participate at the B. Riley Neuro & Ophthalmology Conference finance.yahoo.com Apr 25, 2022 4:00 pm
INmune Bio Announces First Patient Dosed in Phase 2 XPro1595 Trial for Treatment of Neuroinflammation as a Cause of Alzheimers disease finance.yahoo.com Apr 13, 2022 4:00 pm
INmune Bio, Inc. Announces Fourth Quarter and Full Year 2021 Results and Provides Business Update finance.yahoo.com Mar 3, 2022 4:00 pm
INmune Bio, Inc. (INMB) Q3 2021 Earnings Call Transcript fool.com Nov 4, 2021 3:01 am Inmune Bio Stock Flashes Robust RS Rating investors.com Sep 22, 2021 2:44 pm
30 Stocks Moving In Wednesday's Mid-Day Session finance.yahoo.com Sep 8, 2021 12:02 pm
Why Are Shares Of INmune Bio Trading Higher Wednesday Afternoon? finance.yahoo.com Sep 1, 2021 4:45 pm
INmune Bio Stock Jumps On Promising Biomarker Data From Early-Stage Blood Cancer Trial finance.yahoo.com Aug 26, 2021 12:56 pm
INmune Bio, Inc. Announces Design of Upcoming Phase 2 Alzheimers Disease Clinical Trial and New Phase 1b AD Biomarker Data finance.yahoo.com Jul 26, 2021 8:30 am
INmune Bio, Inc. Highlights INKmune Data Featured in NK Cells in Solid Tumors Workshop at Innate Killer Summit finance.yahoo.com Apr 4, 2022 9:00 am This company doesn't provide a dividend.
Talk about INmune Bio below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Very few careers can offer you the freedom, flexibility, and income that day trading does. As a day trader, you can live and work anywhere in the world. You can decide when to work and when not to work. You only answer to yourself. That is the life of the successful day trader. Many people aspire to it, but very few succeed.
A Beginner's Guide to Trading Tools and Tactics, Money Management, Discipline and Trading Psychology